These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Immunomorphologic detection of apoprotein B antigenic determinants in the gallbladder wall in cholesterosis and cholelithiasis]. Ivanchenkova RA, Sviridov AV, Kuznetsov NA, Dadvani SA, Grachev SV. Khirurgiia (Mosk); 2001; (12):19-24. PubMed ID: 11810934 [Abstract] [Full Text] [Related]
7. [Correlation between cholelithiasis and cholesterosis of the gallbladder]. Grosse H. Dtsch Z Verdau Stoffwechselkr; 1987; 47(2):67-71. PubMed ID: 3622359 [Abstract] [Full Text] [Related]
8. [Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment]. Lazebnik LB, Ovsiannikova ON, Zvenigorodskaia LA, Mel'nikova NV, Samsonova NG, Khomeriki SG. Ter Arkh; 2008; 80(1):57-61. PubMed ID: 18326230 [Abstract] [Full Text] [Related]
9. [Clinical and morphological features of gallbladder cholesterosis in children]. Kharitonova LA, Kosareva TM, Kochetova EA, Shakarian KA. Eksp Klin Gastroenterol; 2010; (1):20-4. PubMed ID: 20408262 [Abstract] [Full Text] [Related]
10. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis]. Il'chenko AA, Drozhzhina IuV. Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594 [Abstract] [Full Text] [Related]
12. Xanthogranulomatous cholecystitis: report of seven cases. Reyes CV, Jablokow VR, Reid R. Am Surg; 1981 Jul; 47(7):322-5. PubMed ID: 7258841 [Abstract] [Full Text] [Related]
13. Xanthogranulomatous cholecystitis. A clinicopathological study of 20 cases and review of the literature. Ladefoged C, Lorentzen M. APMIS; 1993 Nov; 101(11):869-75. PubMed ID: 8286095 [Abstract] [Full Text] [Related]
14. Laparoscopic cholecystectomy in the treatment of gallbladder polypoid lesions--15 years of experience. Matłok M, Migaczewski M, Major P, Pędziwiatr M, Budzyński P, Winiarski M, Ostachowski M, Budzyński A, Rembiasz K. Pol Przegl Chir; 2013 Nov; 85(11):625-9. PubMed ID: 24413200 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of cefepime in bile and gall bladder tissue after prophylactic administration in patients with extrahepatic biliary diseases. Petrikkos G, Kastanakis M, Markogiannakis A, Kastanakis S, Bastounis E, Antonios P, Daikos GL, Katsilambros N. Int J Antimicrob Agents; 2006 Apr; 27(4):331-4. PubMed ID: 16563705 [Abstract] [Full Text] [Related]
17. [Efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis]. Il'chenko AA, Orlova IuN. Eksp Klin Gastroenterol; 2003 Apr; (1):46-50, 182. PubMed ID: 12664784 [Abstract] [Full Text] [Related]
18. In search of abnormal enzyme activities of hepatic cholesterol metabolism in patients with cholesterol gallstone disease. Rigotti A, Nervi F. Hepatology; 1991 Dec; 14(6):1295-7. PubMed ID: 1959883 [No Abstract] [Full Text] [Related]